Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Briganti

Showing results (11-20 of 1,746) with videos related to

Pageof 175
Sort By:
European Urology|August 7, 2013
Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's letter to the editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008Firas Abdollah, Alberto Briganti
Nature Reviews. Urology|August 7, 2013
Prostate cancer: AUA-ASTRO guidelines for post-RP radiation fail to go nuclearAlberto Bossi, Alberto Briganti
World Journal of Urology|February 4, 2019
MRI-targeted biopsies: What's next?Guillaume Ploussard, Alberto Briganti
European Urology|April 8, 2015
Words of wisdom. Re: Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohortUmberto Capitanio, Alberto Briganti
International Journal of Urology : Official Journal of the Japanese Urological Association|November 21, 2012
Editorial comment to nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysisUmberto Capitanio, Alberto Briganti
European Urology Focus|September 25, 2020
Re: Kathrin Meisterhofer, Sereina Herzog, Karin A. Strini, Luca Sebastianelli, Ricarda Bauer, Orietta Dalpiaz. Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:575-92Manuela Tutolo, Alberto Briganti, Francesco Montorsi
European Urology|December 25, 2013
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66Piet Ost, Alberto Briganti, Gianluca Giannarini, et al.
Current Opinion in Urology|September 11, 2019
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancerGiuseppe Rosiello, Marco Bandini, Alberto Briganti
European Urology|March 25, 2015
Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9Firas Abdollah, Francesco Montorsi, Alberto Briganti
European Urology Oncology|April 8, 2023
Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16Francesco Montorsi, Marco Moschini, Alberto Briganti
Pageof 175

Showing results (11-20 of 1,746) with videos related to

Sort By:
Pageof 175
European Urology|August 7, 2013
Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's letter to the editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008Firas Abdollah, Alberto Briganti
Nature Reviews. Urology|August 7, 2013
Prostate cancer: AUA-ASTRO guidelines for post-RP radiation fail to go nuclearAlberto Bossi, Alberto Briganti
World Journal of Urology|February 4, 2019
MRI-targeted biopsies: What's next?Guillaume Ploussard, Alberto Briganti
European Urology|April 8, 2015
Words of wisdom. Re: Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohortUmberto Capitanio, Alberto Briganti
International Journal of Urology : Official Journal of the Japanese Urological Association|November 21, 2012
Editorial comment to nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysisUmberto Capitanio, Alberto Briganti
European Urology Focus|September 25, 2020
Re: Kathrin Meisterhofer, Sereina Herzog, Karin A. Strini, Luca Sebastianelli, Ricarda Bauer, Orietta Dalpiaz. Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:575-92Manuela Tutolo, Alberto Briganti, Francesco Montorsi
European Urology|December 25, 2013
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66Piet Ost, Alberto Briganti, Gianluca Giannarini, et al.
Current Opinion in Urology|September 11, 2019
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancerGiuseppe Rosiello, Marco Bandini, Alberto Briganti
European Urology|March 25, 2015
Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9Firas Abdollah, Francesco Montorsi, Alberto Briganti
European Urology Oncology|April 8, 2023
Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16Francesco Montorsi, Marco Moschini, Alberto Briganti
Pageof 175